The effect of propolis supplementation on clinical symptoms in patients with coronavirus (COVID-19): A structured summary of a study protocol for a randomised controlled trial.

ABSTRACT:

Objectives

This study aims to assess the effect of propolis supplementation on clinical symptoms in patients with coronavirus (COVID-19).

Trial design

This is a Double-Blind, Placebo-Controlled, Parallel Arm, Randomized Phase ΙΙ Clinical Trial.

Participants

Patients with the confirmed COVID-19 based on the PCR test are eligible to participate in the trial if they are 18 to 75 years of age and have no history of the current use of warfarin or propolis supplement and presence of sensitivity to bee products. Patients will be recruited from the Al-Zahra hospital in Isfahan city, Isfahan, Iran.

Intervention and comparator

Participants (N=40) in the intervention group will receive an identical propolis tablet (containing 300 mg Iranian green propolis extract) three t

SUBMITTER: Miryan M 

PROVIDER: S-EPMC7713667 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature